References
- Sung, H.; Ferlay, J.; Siegel, R. L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021, 71(3), 209–249. DOI: https://doi.org/10.3322/caac.21660.
- Torre, L. A.; Trabert, B.; DeSantis, C. E.; Miller, K. D.; Samimi, G.; Runowicz, C. D.; Gaudet, M. M.; Jemal, A.; Siegel, R. L. Ovarian Cancer Statistics, 2018. CA Cancer J. Clin. 2018, 68(4), 284–296. DOI: https://doi.org/10.3322/caac.21456.
- Anwar, S. L.; Cahyono, R.; Prabowo, D.; Avanti, W. S.; Choridah, L.; Dwianingsih, E. K.; Harahap, W. A.; Aryandono, T. Metabolic Comorbidities and the Association with Risks of Recurrent Metastatic Disease in Breast Cancer Survivors. BMC Cancer. 2021, 21(1), 590. DOI: https://doi.org/10.1186/s12885-021-08343-0.
- Minlikeeva, A. N.; Freudenheim, J. L.; Eng, K. H.; Cannioto, R. A.; Friel, G.; Szender, J. B.; Segal, B.; Odunsi, K.; Mayor, P.; Diergaarde, B.; et al. History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium. Cancer Epidemiology Biomarkers & Prevention. 2017, 26(9), 1470–1473. DOI: https://doi.org/10.1158/1055-9965.EPI-17-0367.
- Søgaard, M.; Farkas, D. K.; Ehrenstein, V.; Jørgensen, J. O.; Dekkers, O. M.; Sørensen, H. T. Hypothyroidism and Hyperthyroidism and Breast Cancer Risk: A Nationwide Cohort Study. European Journal of Endocrinology. 2016, 174(4), 409–414. DOI: https://doi.org/10.1530/EJE-15-0989.
- Krashin, E.; Piekiełko-Witkowska, A.; Ellis, M.; Ashur-Fabian, O. Thyroid Hormones and Cancer: A Comprehensive Review of Preclinical and Clinical Studies. Front Endocrinol (Lausanne). 2019, 10, 59. Doi:https://doi.org/10.3389/fendo.2019.00059.
- Tosovic, A.; Becker, C.; Bondeson, A. G.; Bondeson, L.; Ericsson, U. B.; Malm, J.; Manjer, J. Prospectively Measured Thyroid Hormones and Thyroid Peroxidase Antibodies in Relation to Breast Cancer Risk. Int. J. Cancer. 2012, 131(9), 2126–2133. DOI: https://doi.org/10.1002/ijc.27470.
- Smyth, P. P.; Smith, D. F.; McDermott, E. W.; Murray, M. J.; Geraghty, J. G.; O’Higgins, N. J. A Direct Relationship between Thyroid Enlargement and Breast Cancer. J. Clin. Endocrinol. Metab. 1996, 81(3), 937–941. DOI: https://doi.org/10.1210/jcem.81.3.8772554.
- Tosovic, A.; Bondeson, A. G.; Bondeson, L.; Ericsson, U. B.; Malm, J.; Manjer, J. Prospectively Measured Triiodothyronine Levels are Positively Associated with Breast Cancer Risk in Postmenopausal Women. Breast Cancer Res. 2010, 12(3), R33. DOI: https://doi.org/10.1186/bcr2587.
- Kuijpens, J.; Nyklíctek, I.; Louwman, M.; Weetman, T.; Pop, V.; Coebergh, J.-W. Hypothyroidism Might Be Related to Breast Cancer in Post-menopausal Women. Thyroid. 2005, 15, 1253–1259. DOI: https://doi.org/10.1089/thy.2005.15.1253.
- Angelousi, A. G.; Anagnostou, V. K.; Stamatakos, M. K.; Georgiopoulos, G. A.; Kontzoglou, K. C. Mechanisms in Endocrinology: Primary HT and Risk for Breast Cancer: A Systematic Review and Meta-analysis. Eur. J. Endocrinol. 2012, 166(3), 373–381. DOI: https://doi.org/10.1530/EJE-11-0838.
- Simon, M. S.; Tang, M. T.; Bernstein, L.; Norman, S. A.; Weiss, L.; Burkman, R. T.; Daling, J. R.; Deapen, D.; Folger, S. G.; Malone, K.; et al. Do Thyroid Disorders Increase the Risk of Breast Cancer? Cancer Epidemiol. Biomarkers Prev. 2002, 11(12), 1574–1578.
- Saraiva, P. P.; Figueiredo, N. B.; Padovani, C. R.; Brentani, M. M.; Nogueira, C. R. Profile of Thyroid Hormones in Breast Cancer Patients. Braz. J. Med. Biol. Res. 2005, 38(5), 761–765. DOI: https://doi.org/10.1590/S0100-879X2005000500014.
- Graceffa, G.; Scerrino, G.; Militello, G.; Laise, I.; Randisi, B.; Melfa, G.; Orlando, G.; Mazzola, S.; Cipolla, C.; Cocorullo, G. Breast Cancer in Previously Thyroidectomized Patients: Which Thyroid Disorders are a Risk Factor? Future Sci. OA. 2021, 7(5), FSO699. DOI: https://doi.org/10.2144/fsoa-2021-0029.
- Martínez-Iglesias, O.; García-Silva, S.; Regadera, J.; Aranda, A. Hypothyroidism Enhances Tumor Invasiveness and Metastasis Development. PloS One. 2009, 4(7), e6428. DOI: https://doi.org/10.1371/journal.pone.0006428.
- Matsumura, Y.; Ito, Y.; Mezawa, Y.; Sulidan, K.; Daigo, Y.; Hiraga, T.; Mogushi, K.; Wali, N.; Suzuki, H.; Itoh, T.; et al. Stromal Fibroblasts Induce Metastatic Tumor Cell Clusters via Epithelial-mesenchymal Plasticity. Life sci alliance. 2019, 2(4), e201900425. DOI: https://doi.org/10.26508/lsa.201900425.
- González-Sancho, J. M.; Figueroa, A.; López-Barahona, M.; López, E.; Beug, H.; Muñoz, A. Inhibition of Proliferation and Expression of T1 and Cyclin D1 Genes by Thyroid Hormone in Mammary Epithelial Cells. Mol. Carcinog. 2002, 34(1), 25–34. DOI: https://doi.org/10.1002/mc.10046.
- Zhang, N.; Jin, W.; Zhou, S.; Yang, J. D.; Harmsen, W. S.; Giama, N. H.; Wongjarupong, N.; Heimbach, J. K.; Watt, K. D.; Malhi, H.; et al. Hypothyroidism Is Associated with Worse Outcomes of Hepatocellular Carcinoma Patients after Liver Transplantation. Cancer Med. 2018, 7(12), 5870–5878. DOI: https://doi.org/10.1002/cam4.1797.
- Frau, C.; Loi, R.; Petrelli, A.; Perra, A.; Menegon, S.; Kowalik, M. A.; Pinna, S.; Leoni, V. P.; Fornari, F.; Gramantieri, L.; et al. Local Hypothyroidism Favors the Progression of Preneoplastic Lesions to Hepatocellular Carcinoma in Rats. Hepatology. 2015, 61(1), 249–259. DOI: https://doi.org/10.1002/hep.27399.
- Hall, L. C.; Salazar, E. P.; Kane, S. R.; Liu, N. Effects of Thyroid Hormones on Human Breast Cancer Cell Proliferation. J. Steroid Biochem. Mol. Biol. 2008, 109(1–2), 57–66. DOI: https://doi.org/10.1016/j.jsbmb.2007.12.008.